Advertisement

Cancer Survivorship

  • Larissa NekhlyudovEmail author
Chapter

Abstract

As of 2016, there are over 15.5 million individuals who have survived or are living with cancer. It is estimated that by 2026, there will be 20.3 million cancer survivors. Cancer survivors are at risk for cancer recurrence and new cancers, and may be experiencing late and long-term effects of treatment causing significant morbidity and premature mortality. This chapter provides an overview of the key issues in caring for this growing population.

K eywords

Cancer survivorship Surveillance Late effects Long-term effects Care coordination 

References

  1. American Cancer Society. Cancer treatment & survivorship facts & figures, 2016–2017. Atlanta: American Cancer Society; 2016.Google Scholar
  2. Bluethmann SM, Mariotto AB, Rowland JH: Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev. 2016;25:1029–36.CrossRefGoogle Scholar
  3. Centers for Disease Control and Prevention. Global cancer statistics. 2015. https://www.cdc.gov/cancer/international/statistics.htm
  4. Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT, et al. Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children's Oncology Group report. Biol Blood Marrow Transplant. 2016 May;22(5):782–95.CrossRefGoogle Scholar
  5. Cohen EE, LaMonte SJ, Erb NL, Beckman KL, Sadeghi N, Hutcheson KA, et al. American Cancer Society head and neck cancer survivorship care guideline. CA Cancer J Clin. 2016 May;66(3):203–39. Epub 2016 Mar 22. Review. Erratum in: CA Cancer J Clin. 2016 Jul;66(4):351.Google Scholar
  6. El-Shami K, Oeffinger KC, Erb NL, Willis A, Bretsch JK, Pratt-Chapman ML, et al. American Cancer Society colorectal cancer survivorship care guidelines. CA Cancer J Clin. 2015 Nov-Dec;65(6):428–55.Google Scholar
  7. Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation; Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT) and Sociedade Brasileira de Transplante de Medula Ossea (SBTMO). Co-published in Biol Blood Marrow Transplant. 2012;18(3):348–71; Bone Marrow Transplant. 2012;47(3):337–41; and Hematol Oncol Stem Cell Ther. 2012;5(1):1–30.CrossRefGoogle Scholar
  8. National Comprehensive Cancer Center Guidelines. https://www.nccn.org/professionals/physician_gls/default.aspx
  9. Nekhlyudov L, Lacchetti C, Davis NB, Garvey TQ, Goldstein DP, Nunnink JC, et al. Head and neck cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement of the American Cancer Society guideline. J Clin Oncol. 2017 May 10;35(14):1606–21.CrossRefGoogle Scholar
  10. Resnick MJ, Lacchetti C, Bergman J, Hauke RJ, Hoffman KE, Kungel TM, et al. Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement. J Clin Oncol. 2015 Mar 20;33(9):1078–85.CrossRefGoogle Scholar
  11. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012. CA Cancer J Clin. 2013 May;63(3):215.Google Scholar
  12. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology breast cancer survivorship care guideline. J Clin Oncol. 2016 Feb 20;34(6):611–35.CrossRefGoogle Scholar
  13. Salani R, Khanna N, Frimer M, Bristow RE, Chen L. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecologic Oncol. 2017;146:3–10.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Division of General Internal Medicine and Primary CareBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations